price target increase

4 articles
The Motley FoolThe Motley Fool··Eric Volkman

JPMorgan Lifts Edgewise Therapeutics on Pipeline Optimism, Stock Surges

JPMorgan raises Edgewise Therapeutics price target to $45, citing positive long-term clinical data for EDG-7500 and sevasemten. Stock rises 2.18%.
AMJBJPMJPMpCJPMpDJPMpJ+5clinical databiotech
The Motley FoolThe Motley Fool··Eric Volkman

ServiceNow Gains on AI Monetization Optimism as BNP Paribas Upgrades Stock

ServiceNow gains on BNP Paribas upgrade to outperform with $140 price target, citing AI monetization success and projected 20% subscription revenue growth.
NOWanalyst upgradeAI monetization
The Motley FoolThe Motley Fool··Rich Smith

Plug Power Surges 23% on Earnings Beat, But Profitability Concerns Linger

Plug Power stock surged 23% on Q4 beat and Wells Fargo's bullish upgrade, but cautious 2026 guidance and delayed profitability raise profitability concerns.
PLUGearnings beatdebt restructuring
The Motley FoolThe Motley Fool··Eric Volkman

TPL Gains on Analyst Upgrade as Power Generation Opportunity Recognized

TPL stock rose on analyst upgrade recognizing power generation opportunity. KeyBanc raised price target to $639, citing AI data center infrastructure potential on Permian Basin lands.
TPLanalyst upgradedata centers